A C. diff (Clostridioides difficile) diet may help alleviate diarrhea (the primary symptom) that is associated with this ...

Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease duration, previous use of corticosteroids, and prior hospitalisation.

A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously difficult-to-treat and potentially life threatening in humans, according to a ...

Clostridioides difficile infection is a major healthcare-associated infection, causing significant morbidity and mortality, ...

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality ...

A real-world study of patients with Clostridioides difficile infection (CDI) in Australia over 10 years shows that fecal ...

The effectiveness of fecal microbiota transplantation in resolving diarrhea associated with C difficile infection is influenced by donor antibiotic use and stool consistency.

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

Meanwhile, A new report from the Health Protection Surveillance Centre (HPSC) found that 605 cases of C diff were reported ...

Fzata, Inc. announces the execution of a clinical trial agreement with the National Institutes of Health (NIH) to sponsor a ...

It was as effective as human fecal transplants in mice against C. difficile infection and with fewer safety concerns. The findings were published in the journal Cell Host & Microbe and the ...